Status: Not yet recruiting
Efficacy of Asciminib in Real-world in Patients With Chronic Myeloid Leukemia in Second or Subsequent Lines
The goal of this observational study is to evaluate the efficacy and tolerability of asciminib in real-life in patients with chronic myeloid leukemia treated in second or subsequent lines. The main object of the study is to assess the achievement of Major Molecular Response.
Participants needed: 98
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Gruppo Italiano Malattie EMatologiche dell'AdultoUpdated: Jun 11, 2026
Eligibility criteria
Patients aged ≥ 18 years and no upper age limit; [+3]
None